[Tolerance ansd effectiveness of a new nitrofurantoin dosage form in healthy subjects and patients with renal insufficiency].
D001702:Biopharmaceutics; D002214:Capsules; D004304:Dosage Forms; D004339:Drug Compounding; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D007668:Kidney / Q000187:drug effects; D007669:Kidney Calculi / Q000188:drug therapy; D007676:Kidney Failure, Chronic / Q000188:drug therapy; D007681:Kidney Papillary Necrosis / Q000188:drug therapy; D008134:Long-Term Care; D008297:Male; D009393:Nephritis / Q000188:drug therapy; D009582:Nitrofurantoin / Q000008:administration & dosage* / Q000009:adverse effects / Q000652:urine; D011704:Pyelonephritis / Q000188:drug therapy; D014548:Urinary Fistula / Q000150:complications; D014552:Urinary Tract Infections / Q000188:drug therapy*
D002214:Capsules; D004304:Dosage Forms; D009582:Nitrofurantoin
Verträglickeits- und Wirksamkeitsuntersuchung bei Gesunden und Niereninsuffizienten mit einer neuen Applikationsform von Nitrofurantoin.